Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Extended Ambulatory Monitoring With iRhythm Zio XT Improves Care of Patients With Hypertrophic Cardiomyopathy

NCT04056715 is registered in ClinicalTrials.gov with iRhythm Technologies, Inc. as lead sponsor.

NCT NCT04056715
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04056715 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Extended Ambulatory Monitoring With iRhythm Zio XT Improves Care of Patients With Hypertrophic Cardiomyopathy
Lead sponsor
iRhythm Technologies, Inc.
Phase
Observational
Overall status
Completed
Start date
January 14, 2020
Completion date
April 18, 2022
Enrollment
250 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmia, atrial fibrillation, hypertrophic cardiomyopathy, nonsustained ventricular tachycardia, ventricular tachycardia